COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience
Since 2020, cases of COVID-19-associated pulmonary aspergillosis (CAPA) have been frequently described, representing an important cause of mortality, especially among patients admitted to intensive care unit (ICU). A predisposition to invasive infection caused by Aspergillus spp. in SARS-CoV-2 infec...
Main Authors: | Alessandro Russo, Riccardo Serraino, Francesca Serapide, Andrea Bruni, Eugenio Garofalo, Federico Longhini, Enrico Maria Trecarichi, Carlo Torti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024003293 |
Similar Items
-
Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
by: Carla M. Román-Montes, et al.
Published: (2022-04-01) -
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
by: Cornelia Lass-Flörl, et al.
Published: (2022-12-01) -
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
by: Alessandro Russo, et al.
Published: (2022-06-01) -
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
by: Alessandro Russo, et al.
Published: (2020-07-01) -
Invasive <i>Aspergillosis</i> in the Intensive Care Unit
by: Liam Townsend, et al.
Published: (2022-11-01)